Redeye maintains its fair value range on the back of a somewhat weaker report than forecast. The case remains intact, however, and we believe the Company boasts good conditions for future growth. XMReality completed a large capital raise during the quarter and will predominantly invest in its go to market. Our Base Case is SEK 10.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/